Korean Stock
EXCH
Yuhan
★
Notice of 2026 R&D Day
 20h ago
EXCH
Yuhan
★
Signed 210.2 Billion KRW API Supply Contract with Gilead (9.6% of Sales)
 22h ago
OWNR
Yuhan
★
No Change in Specific Securities Ownership Report
 05/16/2026, 07:51 PM
OWNR
Yuhan
★
Insider Ownership Report with No Change in Stake
 05/16/2026, 07:51 PM
OWNR
Yuhan
★
Submission of Insider Ownership Report
 05/16/2026, 07:51 PM
EXCH
Yuhan
★
Q1 2026 Business Results IR Meeting
 05/16/2026, 07:51 PM
PERI
Yuhan
★★★★
Yuhan Corporation Q1 2026: Revenue up 7.2%, Operating Profit up 37.3% – Lazertinib Global Approvals and Enhanced Shareholder Returns via Treasury Share Cancellation
 05/15/2026, 04:24 PM
EXCH
Yuhan
★★★★
Lazertinib European Commercialization Milestone Achieved, $30M Payment Received
 05/14/2026, 11:05 AM
EXCH
Yuhan
★
ImmuneOncia Rights Offering Finalized at 4,860 Won, Operating Funds Adjusted to 81.8B Won
 05/11/2026, 05:23 PM
OWNR
Yuhan
★
Simplified Large Shareholding Report Template - No Specific Data
 05/11/2026, 04:18 PM